Marine-Derived Products for Biomedicine
The sustainable exploitation of marine biodiversity is one structural column of the "blue economy", and the discovery of new compounds and materials to be used in biomedicine is considered one of the most strategic activities, within an economic context. An exhaustive selection of the diff...
| Format: | eBook |
|---|---|
| Language: | English |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2020
|
| Subjects: | |
| Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
| LEADER | 04163namaa2201153uu 4500 | ||
|---|---|---|---|
| 001 | doab69181 | ||
| 003 | oapen | ||
| 005 | 20210501 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 210501s2020 xx |||||o ||| 0|eng d | ||
| 020 | |a 9783039431304 | ||
| 020 | |a 9783039431311 | ||
| 020 | |a books978-3-03943-131-1 | ||
| 024 | 7 | |a 10.3390/books978-3-03943-131-1 |2 doi | |
| 040 | |a oapen |c oapen | ||
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a TB |2 bicssc | |
| 720 | 1 | |a Giovine, Marco |4 edt | |
| 720 | 1 | |a Giovine, Marco |4 oth | |
| 245 | 0 | 0 | |a Marine-Derived Products for Biomedicine |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2020 | ||
| 300 | |a 1 online resource (214 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
| 520 | |a The sustainable exploitation of marine biodiversity is one structural column of the "blue economy", and the discovery of new compounds and materials to be used in biomedicine is considered one of the most strategic activities, within an economic context. An exhaustive selection of the different typologies of approaches used by marine biotechnologists to develop research on these topics are demonstrated in the eight original articles and two reviews comprising this Special Issue. The reported scientific publications describe the discovery of new compounds for cancer therapy or for the control of bacterial virulence. Different new uses of marine chitin or chitosan-based materials are also shown for the first time, as well as novel green techniques for the extraction of compounds from marine algae or from fishery waste, which are described in the two reviews. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Technology: general issues |2 bicssc | |
| 653 | |a anti-tumors | ||
| 653 | |a antibiofilm | ||
| 653 | |a bioactive compounds | ||
| 653 | |a biodiversity | ||
| 653 | |a biofuels | ||
| 653 | |a biological materials | ||
| 653 | |a biomaterials | ||
| 653 | |a bioprocessing | ||
| 653 | |a brain | ||
| 653 | |a cancer | ||
| 653 | |a chitin | ||
| 653 | |a chitosan | ||
| 653 | |a Chondrosia reniformis | ||
| 653 | |a Chondrosin | ||
| 653 | |a clinical studies | ||
| 653 | |a Cyanobacteria | ||
| 653 | |a cytotoxic protein | ||
| 653 | |a demosponges | ||
| 653 | |a echinochrome A | ||
| 653 | |a enzyme | ||
| 653 | |a estradiol | ||
| 653 | |a extracellular matrix | ||
| 653 | |a Extracellular Polymeric Substances | ||
| 653 | |a fucoidan | ||
| 653 | |a green extractions | ||
| 653 | |a hydrogel | ||
| 653 | |a hydrogels | ||
| 653 | |a in vitro | ||
| 653 | |a in vivo | ||
| 653 | |a ionic liquids | ||
| 653 | |a laser stereolithography | ||
| 653 | |a long-term stability | ||
| 653 | |a marine | ||
| 653 | |a marine polymers | ||
| 653 | |a marine toxin | ||
| 653 | |a mechanochemical synthesis | ||
| 653 | |a membranes | ||
| 653 | |a mesenchymal stem cells | ||
| 653 | |a microalgae | ||
| 653 | |a microbes | ||
| 653 | |a motility | ||
| 653 | |a n-3 fatty acids | ||
| 653 | |a nanoparticles | ||
| 653 | |a omega 3 | ||
| 653 | |a ovariectomy | ||
| 653 | |a pharmaceutical | ||
| 653 | |a Porifera | ||
| 653 | |a prevention | ||
| 653 | |a prodigiosin | ||
| 653 | |a Pseudoceratina arabica | ||
| 653 | |a Pseudomonas aeruginosa | ||
| 653 | |a PUFA | ||
| 653 | |a scaffold | ||
| 653 | |a scaffolds | ||
| 653 | |a secondary metabolites | ||
| 653 | |a Serratia marcescens | ||
| 653 | |a sponges | ||
| 653 | |a therapy | ||
| 653 | |a tissue engineering | ||
| 653 | |a tissue reaction | ||
| 653 | |a Trichormus variabilis | ||
| 653 | |a virulence factors | ||
| 653 | |a vocal fold | ||
| 653 | |a α-Chitin | ||
| 793 | 0 | |a DOAB Library. | |
| 856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/69181 |7 0 |z Open Access: DOAB: description of the publication |
| 856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/2953 |7 0 |z Open Access: DOAB, download the publication |